What is Global Cannabigerol (CBG) Market?
The Global Cannabigerol (CBG) Market refers to the worldwide industry focused on the production, distribution, and sale of products containing Cannabigerol, a non-psychoactive cannabinoid found in the cannabis plant. CBG is often referred to as the "mother of all cannabinoids" because it is the precursor to other cannabinoids like THC and CBD. The market encompasses a variety of products, including oils, tinctures, isolates, and capsules, which are used for various health and wellness purposes. The increasing interest in CBG is driven by its potential therapeutic benefits, such as anti-inflammatory, antibacterial, and neuroprotective properties. As research continues to uncover the benefits of CBG, the market is expected to grow, attracting more consumers and businesses. The global CBG market is characterized by a diverse range of products and applications, making it a dynamic and rapidly evolving sector within the broader cannabis industry.
Full Spectrum CBG Oil, THC-free CBG Tincture, CBG Isolate, CBG Softgel Capsules, Others in the Global Cannabigerol (CBG) Market:
Full Spectrum CBG Oil, THC-free CBG Tincture, CBG Isolate, CBG Softgel Capsules, and other CBG products are integral components of the Global Cannabigerol (CBG) Market. Full Spectrum CBG Oil contains a wide range of cannabinoids, terpenes, and other beneficial compounds found in the cannabis plant, excluding THC. This type of oil is popular among users who seek the entourage effect, where multiple cannabinoids work together to enhance therapeutic benefits. THC-free CBG Tincture, on the other hand, is specifically formulated to exclude THC, making it an ideal choice for individuals who want to avoid any psychoactive effects. These tinctures are typically taken sublingually, allowing for quick absorption into the bloodstream. CBG Isolate is a pure form of Cannabigerol, often available in powder or crystalline form. It is highly versatile and can be used in various applications, including edibles, topicals, and vape products. CBG Softgel Capsules offer a convenient and precise way to consume CBG, with each capsule containing a specific dosage. This form is particularly appealing to those who prefer a straightforward and consistent method of ingestion. Other CBG products in the market include topicals, such as creams and balms, which are applied directly to the skin for localized relief. Additionally, CBG-infused edibles, like gummies and chocolates, provide a tasty and discreet way to consume Cannabigerol. The diversity of CBG products caters to a wide range of consumer preferences and needs, contributing to the overall growth and development of the Global Cannabigerol (CBG) Market.
Medicinal, Relieve Stress, Pain Relief, Others in the Global Cannabigerol (CBG) Market:
The usage of Global Cannabigerol (CBG) Market products spans various areas, including medicinal applications, stress relief, pain relief, and other health and wellness benefits. In the medicinal field, CBG is being explored for its potential to treat a variety of conditions. Research suggests that CBG may have neuroprotective properties, making it a promising candidate for the treatment of neurodegenerative diseases like Huntington's disease. Additionally, its antibacterial properties are being studied for their effectiveness against antibiotic-resistant bacteria. For stress relief, CBG products are gaining popularity due to their potential to promote relaxation and reduce anxiety without the psychoactive effects associated with THC. Many users report feeling calmer and more balanced after using CBG, making it a valuable tool for managing daily stress. Pain relief is another significant area where CBG is making an impact. Its anti-inflammatory properties can help alleviate chronic pain conditions, such as arthritis and fibromyalgia. Users often turn to CBG as a natural alternative to traditional pain medications, which can have undesirable side effects. Beyond these primary uses, CBG is also being incorporated into skincare products for its potential to improve skin health. Its anti-inflammatory and antibacterial properties make it beneficial for conditions like acne and psoriasis. Additionally, CBG is being explored for its potential to support eye health, with studies indicating it may help reduce intraocular pressure, a key factor in glaucoma. The versatility of CBG and its wide range of applications make it a valuable addition to the health and wellness industry, driving the growth of the Global Cannabigerol (CBG) Market.
Global Cannabigerol (CBG) Market Outlook:
The global Cannabigerol (CBG) market was valued at approximately US$ 6,834.2 million in 2023 and is projected to reach around US$ 16,070 million by 2030, reflecting a compound annual growth rate (CAGR) of 13.9% during the forecast period from 2024 to 2030. This significant growth is indicative of the increasing recognition and acceptance of CBG's potential benefits across various sectors. The rising demand for natural and alternative health solutions is a key driver of this market expansion. As more consumers become aware of the therapeutic properties of CBG, such as its anti-inflammatory, antibacterial, and neuroprotective effects, the market is expected to continue its upward trajectory. Additionally, advancements in cannabis research and the development of new CBG-infused products are likely to further fuel market growth. The expanding legal framework for cannabis and its derivatives in various regions also plays a crucial role in the market's development. As regulations become more favorable, more companies are entering the market, contributing to increased competition and innovation. Overall, the global Cannabigerol (CBG) market is poised for substantial growth, driven by a combination of consumer demand, scientific research, and regulatory advancements.
| Report Metric | Details |
| Report Name | Cannabigerol (CBG) Market |
| Accounted market size in 2023 | US$ 6834.2 million |
| Forecasted market size in 2030 | US$ 16070 million |
| CAGR | 13.9% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Hempsana Holdings, Willow Biosciences, Precision Plant Molecules, Bright Green Corporation, Hemptown, Charlotte's Web, Green Road, Demetrix, Canatura, CannaCare, FAB CBD, CBDistillery, Medterra CBD, NuLeaf Naturals, Lazarus Naturals, Avikana, Incr-edibles, Vida Optima |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
